NOVN.SW: Novartis AG Stock Live Price Graph
About the company
Novartis AG is a global pharmaceutical company dedicated to the discovery, development, production, and commercialization of a broad spectrum of healthcare solutions. Its business operations are segmented into two primary divisions: Innovative Medicines and Sandoz. The Innovative Medicines segment concentrates on delivering prescription medications to both patients and medical professionals. This division's extensive product portfolio addresses various therapeutic areas, including ophthalmology, neurological disorders, immunological conditions, liver diseases, dermatological ailments, respiratory illnesses, cardiovascular health, renal conditions, and metabolic imbalances. Conversely, the Sandoz division specializes in the development, manufacturing, and marketing of finished generic medications. It also supplies active pharmaceutical ingredients (APIs), including antibiotics and other intermediates, along with complete small-molecule pharmaceutical products to external companies. This segment's offerings further encompass retail generics, anti-infective treatments, and biotechnology-derived products such as biosimilars, in addition to providing specialized biotechnology manufacturing services. In terms of strategic alliances, Novartis AG maintains a licensing and collaborative agreement with Alnylam Pharmaceuticals for the development, production, and market introduction of inclisiran. Furthermore, the company is engaged in a clinical partnership with Kura Oncology, Inc., focused on evaluating the combined effectiveness of Tipifarnib and Alpelisib in individuals suffering from head and neck squamous cell carcinoma. Established in 1996, the corporation maintains its headquarters in Basel, Switzerland.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $3.7 | $3.7 | 3.03% | - |
| - | $3.5 | $3.5 | 3.66% | - |
| - | $3.3 | $3.3 | 3.76% | - |
| - | $3.84 | $3.84 | 4.24% | - |
| - | $3.1 | $3.1 | 4.17% | - |
| - | $3 | $3 | 3.84% | - |
| - | $2.95 | $2.95 | 3.64% | - |
| - | $2.85 | $2.85 | 3.62% | - |
| - | $2.8 | $2.8 | 4.14% | - |
| - | $2.75 | $2.75 | 4.10% | - |
| - | $2.7 | $2.7 | 4.27% | - |
| - | $2.6 | $2.6 | 3.10% | - |
| - | $2.45 | $2.45 | 3.78% | - |
| - | $2.3 | $2.3 | 4.18% | - |
| - | $2.25 | $2.25 | 5.12% | - |
| - | $2.2 | $2.2 | 4.87% | - |
| - | $2.1 | $2.1 | 4.04% | - |
| - | $2 | $2 | 5.30% | - |
| - | $1.6 | $1.6 | 3.52% | - |
| - | $1.35 | $1.35 | 2.20% | - |
| - | $1.15 | $1.15 | 1.85% | - |
| - | $1.05 | $1.05 | 2.05% | - |
| - | $1 | $1 | 2.02% | - |
| - | $0.95 | $0.95 | 2.25% | - |
| - | $0.9 | $0.9 | 1.55% | - |
| - | $34 | $34 | 1.51% | - |
| - | $32 | $32 | 1.63% | - |
| - | $29 | $29 | 1.55% | - |
| - | $25 | $25 | 1.26% | - |
| - | $20 | $20 | 1.27% | - |
What Is NOVN.SW? Live NOVN.SW Prices and Analysis
NOVN.SW, also known as Novartis AG, is a leading global healthcare company based in Switzerland that focuses on research, development, manufacturing, and marketing of a wide range of healthcare products, including pharmaceuticals and generics. With its robust portfolio and commitment to innovation, Novartis plays a significant role in the pharmaceutical sector, making it an important company for investors to monitor.
Investors follow NOVN.SW due to its substantial market presence, consistent performance, and the potential for growth in the healthcare industry. The company’s focus on innovative treatments and therapies addresses critical healthcare needs, thereby influencing its stock performance and market sentiment.
In recent years, the healthcare sector has gained prominence, especially in light of global health challenges. As a result, stocks like NOVN.SW have attracted attention from both institutional and retail investors, making it essential to analyze its performance and market trends.
Market Context
Trading of NOVN.SW occurs primarily on the SIX Swiss Exchange, with the Swiss Franc (CHF) as its pricing currency. The stock has exhibited volatility, which is common in the healthcare sector, influenced by various factors including regulatory changes, patent expirations, and market dynamics. Investors must remain aware of how international trading conditions and currency fluctuations can impact stock prices.
Why Do NOVN.SW Prices Rise or Fall?
The price of NOVN.SW stock can fluctuate due to several factors that impact market sentiment and investor confidence. Understanding these factors is crucial for making informed investment decisions.
- Earnings Reports: Quarterly earnings reports can heavily influence stock prices, as they provide insights into the company's financial health.
- Drug Approvals: The approval or rejection of new drugs by regulatory authorities can lead to significant price movements.
- Market Competition: The introduction of competing drugs can affect Novartis' market share and revenue potential.
- Global Health Trends: Changes in global health needs can impact demand for Novartis products.
- Economic Indicators: Broader economic conditions and indicators such as GDP growth can influence investor sentiment.
- Dividends: Changes in dividend policies can affect investor interest and stock prices.
- Regulatory Changes: New regulations impacting the healthcare sector can create uncertainty and affect stock performance.
- Market Sentiment: Overall sentiment towards the healthcare sector can lead to price fluctuations.
In summary, the interplay of these factors creates a dynamic environment that can cause NOVN.SW prices to rise or fall, making it essential for investors to stay informed.
Why Is Live NOVN.SW Price Tracking Important?
Tracking the live price of NOVN.SW is crucial for investors for several reasons:
- Timely Decision Making: Access to real-time prices allows investors to make informed trading decisions quickly.
- Market Trends: Observing price trends can help identify potential investment opportunities.
- Risk Management: Monitoring live prices aids in managing risk and adjusting investment strategies as needed.
- Understanding Volatility: Live tracking helps investors understand the volatility of the stock and plan accordingly.
- Performance Assessment: Investors can evaluate the performance of their investments against market benchmarks.
What Should You Consider When Trading / Investing in NOVN.SW?
When considering an investment in NOVN.SW, investors should take into account various aspects:
- Risk Factors: The pharmaceutical industry carries inherent risks, including regulatory hurdles and market competition.
- Macro Data: Economic indicators and healthcare spending trends can impact stock performance.
- Volatility Warnings: Be prepared for potential volatility, especially around earnings reports or drug approval announcements.
- Long-term vs Short-term: Determine your investment strategy—whether you are looking for short-term gains or long-term stability.
What Can You Find on the Investvio NOVN.SW Page?
- Live Price: Current market price of NOVN.SW.
- Charts: Interactive charts showing historical price trends and performance.
- Technical Analysis: Insights into stock performance based on technical indicators.
- News: Latest news and updates related to Novartis and the healthcare sector.
- Earnings Reports: Access to historical and upcoming earnings announcements.
- Dividend Information: Details on dividends, including yield and payment history.
In conclusion, the Investvio page for NOVN.SW offers a comprehensive view of the stock, providing essential tools and information for investors to make informed decisions in the dynamic healthcare sector.